Zhu et al. (54) found that NPM1 promoted aerobic glycolysis and tumor progression in patients with pancreatic cancer by inhibiting the fructose-1, 6-bisphosphatase 1. The gene discussed is FBP1; the disease is pancreatic neoplasm.